|
 The Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise of the Department of Biotechnology (DBT), Government of India, is showcasing its innovation and start-up ecosystem at a dedicated pavilion during the Bharatiya Vyapar Mahotsav (BVM) 2026, being held from August 12–15 at Bharat Mandapam, Pragati Maidan, New Delhi.
Organised jointly by the Confederation of All India Traders (CAIT) and India Trade Promotion Organisation (ITPO), BVM 2026 is one of the country's largest platforms celebrating "Made in India, Made for India, Made for the World," bringing together traders, MSMEs, manufacturers, institutions, investors and policymakers from across the country.
The BIRAC pavilion offers visitors, investors, industry leaders and the public an opportunity to engage directly with some of India's most promising biotech and medtech innovators, and to understand how BIRAC's ecosystem of schemes, funding instruments and enabling infrastructure is helping translate laboratory research into affordable, market-ready products.
Since its establishment, BIRAC has positioned itself as a critical bridge between India's scientific research base and the industry, helping convert cutting-edge ideas into viable enterprises and, eventually, into products that reach patients, farmers and citizens. As an industry–academia interface agency under DBT, BIRAC has built one of the country's most extensive networks of incubators, bioclusters, accelerators and funding schemes, supporting entrepreneurs at every stage — from proof-of-concept to commercialisation.
A significant share of the start-ups featured at the BIRAC pavilion this year work at the intersection of medical technology and social impact — developing affordable prosthetics, robotic rehabilitation systems, and assistive devices for persons with disabilities. This reflects BIRAC's continued emphasis on social innovation as a core component of its mandate: ensuring that advanced biotechnology and medtech innovation also serves India's most vulnerable populations.
"BIRAC's role has always gone beyond funding — to de-risk the innovation journey for India's biotech entrepreneurs, connecting them to capital, infrastructure, mentorship and markets at every stage. The start-ups showcased at our pavilion this year, many of them working on assistive technologies and rehabilitation solutions, are a powerful example of how Indian innovation can be both cutting-edge and deeply inclusive. Platforms like the Bharatiya Vyapar Mahotsav allow us to bring these home-grown solutions closer to industry, investors and the public, and to reaffirm BIRAC's commitment to building a self-reliant, globally competitive Indian bio-economy." — Dr. Dhananjay Kumar Tiwary, managing director, BIRAC
|